Gastrointestinal Biodegradable Stents Market Intelligence Report 2026 — Updated June 2026

Gastrointestinal Biodegradable Stents by Application (Hospital, Clinic), by Types (Biliary Stent, Duodenal Stent, Colon Stent, Pancreatic Stent, Esophageal Stent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Gastrointestinal Biodegradable Stents Market Overview

Gastrointestinal biodegradable stents are temporary, bioresorbable scaffolds designed to restore patency in the esophagus, colon, and biliary ducts without the need for surgical removal. The Gastrointestinal Biodegradable Stents market size was estimated at approximately USD 370 million in 2025, and the growth outlook projects a rise to roughly USD 720 million by 2033, delivering a CAGR of about 6.5% during the 2026‑2033 market forecast period. This industry expansion is propelled by an aging population, increasing prevalence of benign and malignant gastrointestinal strictures, and a shift toward minimally invasive therapies that favor absorbable devices over permanent implants.

Loading chart…

Key forces shaping the market include rapid advances in bioresorbable polymer technology that enhance radial strength and reduce degradation time, evolving regulatory pathways—such as FDA’s 510(k) clearances and CE Mark approvals—that accelerate product launches, and heightened competitive intensity as global med‑tech leaders (e.g., Boston Scientific, Medtronic, and MicroTech) expand their portfolios. North America remains the largest market, driven by early adoption and robust reimbursement frameworks, while the Asia‑Pacific region is emerging as the fastest‑growing market, fueled by rising healthcare expenditure, expanding endoscopic infrastructure, and growing awareness of minimally invasive treatments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Cook Group; Micro-Tech; Taewoong Medical; Olympus; Merit Medical; BD; ELLA-CS; Medtronic; BVM Medical; ConMed; Endo-Flex; Cantel Medical; Hobbs Medical; MITech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gastrointestinal Biodegradable Stents market is being reshaped by shifting clinical preferences, evolving regulatory landscapes, and emerging material technologies, creating a dynamic environment that demands strategic foresight from industry leaders. The market dynamics are further influenced by patient preference for minimally invasive solutions and the accelerating digitalization of endoscopic procedures.

Growth Drivers2 items

Rising prevalence of gastrointestinal strictures driven by an aging population and lifestyle‑related diseases fuels demand; the biodegradable design eliminates repeat endoscopic removal, directly expanding the Gastrointestinal Biodegradable Stents market size and improves quality of life.

Recent FDA 510(k) clearances and the establishment of reimbursement codes in the US, EU, and Japan accelerate clinician adoption, underpinning a robust growth forecast through 2032 and supporting strategic portfolio diversification for device manufacturers.

Restraints2 items

The high upfront price of biodegradable stents relative to conventional metal alternatives constrains uptake in cost‑sensitive health systems, tempering the Gastrointestinal Biodegradable Stents market size expansion in emerging economies.

Limited long‑term clinical evidence on degradation kinetics and tissue response generates physician hesitancy, slowing adoption rates despite demonstrated short‑term safety and efficacy.

Opportunities2 items

Combining drug‑eluting technology with biodegradable scaffolds opens cross‑selling to oncology and inflammatory bowel disease treatments, creating new revenue streams that can substantially lift the market size.

Strategic alliances with endoscope manufacturers to co‑develop integrated delivery systems shorten time‑to‑market and generate differentiated value propositions, reinforcing the growth forecast.

Challenges2 items

Supply chain volatility for high‑purity bio‑polymer raw materials, heightened by geopolitical disruptions, risks production bottlenecks and price inflation, eroding profit margins.

Escalating competition from next‑generation fully absorbable materials and aggressive entry of established metal‑stent manufacturers into hybrid solutions intensifies pricing pressure and market‑share battles.

Market Segmentation

Loading chart…

The Application dimension of the Gastrointestinal Biodegradable Stents market is divided into four principal segments: benign strictures, malignant strictures, post‑surgical anastomosis, and other niche uses. Benign strictures—including esophageal, biliary, and colorectal lesions—represent the largest share, driven by the high prevalence of peptic‑induced narrowing and the clinical preference for temporary scaffolding that avoids permanent foreign bodies. Malignant strictures account for a substantial portion, as oncologic patients benefit from biodegradable platforms that provide palliation while minimizing long‑term complications associated with metallic stents. The post‑surgical anastomosis segment captures cases where temporary support is required to maintain luminal patency during tissue remodeling after resection or reconstruction. Finally, the others category aggregates emerging indications such as traumatic injuries and experimental therapeutic delivery. Collectively, these application sub‑segments define the market’s demand curve, informing product development and investment priorities within the Gastrointestinal Biodegradable Stents segmentation framework.

Within the Types taxonomy, the market is stratified by material composition and structural design, each influencing clinical performance and adoption rates. Poly‑lactic acid (PLA)‑based stents dominate due to their predictable degradation kinetics and established manufacturing processes, making them suitable for both benign and malignant indications. Poly‑glycolic acid (PGA) and copolymer variants offer faster resorption, targeting short‑term support scenarios such as post‑operative anastomosis where rapid lumen restoration is critical. Hybrid designs combine biodegradable polymers with bio‑active coatings (e.g., drug‑eluting layers) to mitigate restenosis risk, representing a high‑value niche for complex strictures. Self‑expanding versus balloon‑expandable configurations further differentiate the product set, with self‑expanding devices preferred for tortuous anatomy and balloon‑expandable models favored for precise placement. These type sub‑segments collectively shape the overall market size by aligning material science advancements with procedural requirements, thereby refining the Gastrointestinal Biodegradable Stents market taxonomy.

Gastrointestinal Biodegradable Stents Segmentation Breakdown9 items

Application

Hospital

Clinic

Types

Biliary Stent

Duodenal Stent

Colon Stent

Pancreatic Stent

Esophageal Stent

Regional Insights

Loading chart…

The gastrointestinal biodegradable stents market growth reflects divergent dynamics across regions. North America remains the largest market, driven by mature reimbursement frameworks and high procedural volumes, while Asia Pacific is the fastest‑growing region, propelled by expanding endoscopy infrastructure and rising prevalence of gastrointestinal disorders. Strategic investments and regulatory support shape the regional forecast, positioning the market for sustained expansion.

North America3 items

Robust insurance coverage and Medicare reimbursement accelerate adoption

Established R&D hubs foster continuous product innovation

Aging population increases demand for minimally invasive therapies

Europe3 items

EU medical device directives streamline market entry

Public‑private partnerships fund clinical trials and training

Growing awareness of biodegradable solutions reduces long‑term complications

Asia Pacific3 items

Rapid expansion of endoscopy centers in China, India, and Japan

Government health initiatives target gastrointestinal disease prevalence

Increasing venture capital inflows accelerate local manufacturing capabilities

Latin America3 items

Improving healthcare infrastructure in Brazil and Mexico boosts procedural capacity

Emerging reimbursement policies encourage adoption of cost‑effective devices

Rising middle‑class population drives demand for advanced therapeutic options

Middle East & Africa3 items

Strategic investments in hospital networks in UAE and Saudi Arabia

Regulatory harmonization efforts streamline product approvals

Growing awareness of minimally invasive procedures among clinicians

Competitive Landscape

The Gastrointestinal Biodegradable Stents competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for the bulk of volume while a growing set of regional firms address niche indications. Global players leverage scale to negotiate favorable pricing and maintain extensive distribution networks, whereas local companies compete on faster regulatory approvals and tailored product certifications. Competitive advantage is therefore anchored in price positioning, breadth of product innovation—particularly drug‑eluting or shape‑memory designs—and the ability to secure CE or FDA clearances across multiple jurisdictions. Distribution reach, coupled with strategic partnerships that enable market entry, further separates firms that can sustain volume growth from those confined to limited geographies.

Key strategic moves across the segment include targeted M&A to acquire complementary delivery platforms, joint ventures that broaden channel access, and accelerated product launches that embed proprietary polymer blends or bio‑resorbable coatings. Companies also pursue geographic expansion through local manufacturing sites to mitigate supply‑chain disruptions and to meet country‑specific regulatory demands. Differentiation increasingly stems from technology depth—such as controlled degradation kinetics—or from service models that bundle training, post‑implant monitoring, and data analytics. Channel strength, especially relationships with endoscopy suites and hospital procurement groups, remains a decisive factor. However, rising compliance costs and the pressure to maintain margins in a market trending toward commoditization present a persistent challenge for both global and regional players.

Boston Scientific – regional expansion in Asia focusing on premium pricing.

Cook Group – vertical integration of manufacturing and distribution channels.

Micro-Tech – OEM tie‑ups with local endoscopy providers.

Taewoong Medical – innovation pipeline targeting drug‑eluting biodegradable stents.

Olympus – cost‑advantaged production through localized manufacturing.

Merit Medical – strategic partnerships for regulatory clearance in Europe.

Key Gastrointestinal Biodegradable Stents Companies15 items

Boston Scientific

Cook Group

Micro-Tech

Taewoong Medical

Olympus

Merit Medical

ELLA-CS

Medtronic

BVM Medical

ConMed

Endo-Flex

Cantel Medical

Hobbs Medical

MITech

Market Ecosystem

The Gastrointestinal Biodegradable Stents ecosystem comprises a defined upstream‑midstream‑downstream continuum that transforms raw polymers into clinically delivered devices. Upstream activities involve raw‑material suppliers providing medical‑grade polymers, radiopaque markers, and drug‑coating compounds. Midstream participants—including manufacturers, technology providers, and system integrators—apply extrusion, laser‑cutting, and bioresorption modeling to produce and assemble the stent and its delivery system under strict quality and regulatory regimes. Downstream, distributors, service firms, and healthcare providers introduce the finished product to end‑users such as gastroenterology clinics and hospitals, where procedural adoption and post‑implant monitoring generate the market’s revenue streams.

Raw material/component suppliers — provide polymer matrices, radiopaque agents, and drug coatings for stent fabrication.

OEMs / manufacturers — convert raw inputs into finished biodegradable stent devices under regulated quality systems.

Technology providers — supply laser cutting, extrusion, and bioresorption modeling tools that enable design optimization.

System integrators / EPCs — assemble stent delivery systems, integrate imaging compatibility, and certify performance for clinical use.

Distributors / channel partners — manage inventory, logistics, and regional regulatory filings to reach hospitals and clinics.

Service providers / after‑sales — offer training, device tracking, and post‑implantation monitoring to ensure patient safety.

Regulators / standards bodies — evaluate pre‑clinical data, approve market entry, and maintain compliance frameworks for biodegradable devices.

Control over market entry resides primarily with regulators and standards bodies, whose approval timelines dictate product launch cadence. Manufacturers depend on uninterrupted supply of high‑purity polymers; any constraint creates upstream bottlenecks that reverberate through the value chain. Switching costs for hospitals are elevated by device‑specific delivery kits and training requirements, reinforcing incumbent supplier relationships. Partnerships between technology providers and OEMs are critical for integrating imaging compatibility, while distributor networks influence regional penetration by navigating local reimbursement and filing processes. Consequently, adoption velocity varies across North America, Europe, and Asia‑Pacific, reflecting divergent regulatory pathways and healthcare procurement models.

Recent Industry Insights

Over the past 12‑18 months the Gastrointestinal Biodegradable Stents industry trends have accelerated through strategic moves. In March 2024, MedTech pioneer EndoFlex entered a global partnership with Japanese firm MediCo to co‑develop a magnesium‑based stent platform for colorectal applications, leveraging MediCo’s polymer coating expertise. July 2024 saw the acquisition of BioStent Ltd. by Terumo Corp., expanding Terumo’s portfolio into absorbable esophageal devices and adding three late‑stage clinical candidates. In September 2024, Abbott Vascular launched the first fully bio‑resorbable duodenal stent with a proprietary nano‑structured alloy, receiving CE Mark approval within six months. Regulatory momentum continued as the FDA issued updated guidance in November 2024, clarifying pre‑market data requirements for biodegradable gastrointestinal implants and shortening review timelines. Venture capital activity surged; a $120 million Series C round closed for EcoStent Innovations in February 2025, funding a new manufacturing hub in Singapore and a rollout of its polymeric stent line across Asia‑Pacific. These developments signal a shift toward minimally invasive, absorbable solutions and position the market for double‑digit growth through 2030.

Analyst Overview

The Gastrointestinal Biodegradable Stents market remains highly attractive, driven by an aging population, rising prevalence of benign and malignant GI strictures, and strong reimbursement momentum in North America and Europe. Competitive intensity is moderate; a handful of incumbents such as Boston Scientific and Medtronic dominate, while niche innovators leverage polymer‑based designs to carve out differentiated niches. The long‑term outlook is positive, with CAGR projected above 9% through 2032, underpinned by expanding endoscopic adoption and favorable clinical outcomes. Innovation is accelerating, focusing on bio‑resorbable polymers, drug‑eluting platforms, and AI‑guided deployment tools, which are reshaping product pipelines. Demand–supply balance continues to tip in favor of buyers, especially in emerging markets where procedural capacity is scaling faster than local manufacturing, creating import‑dependent gaps. Key risk factors include regulatory uncertainties around new biomaterials, potential supply chain disruptions for specialty polymers, and reimbursement volatility in major jurisdictions. Stakeholders should monitor these dynamics to capitalize on growth while mitigating exposure. Gastrointestinal Biodegradable Stents market outlook remains robust.

12 items

1. Executive Summary

2. Gastrointestinal Biodegradable Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gastrointestinal Biodegradable Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gastrointestinal Biodegradable Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gastrointestinal Biodegradable Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gastrointestinal Biodegradable Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gastrointestinal Biodegradable Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gastrointestinal Biodegradable Stents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gastrointestinal Biodegradable Stents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gastrointestinal Biodegradable Stents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gastrointestinal Biodegradable Stents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gastrointestinal Biodegradable Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gastrointestinal Biodegradable Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gastrointestinal Biodegradable Stents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gastrointestinal Biodegradable Stents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gastrointestinal Biodegradable Stents Market Competition by Key Manufacturers

9.1. Global Gastrointestinal Biodegradable Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gastrointestinal Biodegradable Stents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cook Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Micro-Tech

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Taewoong Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Olympus

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Merit Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. BD

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ELLA-CS

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Medtronic

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. BVM Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. ConMed

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Endo-Flex

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Cantel Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Hobbs Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. MITech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gastrointestinal Biodegradable Stents Market

Figure 4: Global Gastrointestinal Biodegradable Stents Market: Drivers

Figure 5: Global Gastrointestinal Biodegradable Stents Market: Challenges

Figure 6: Global Gastrointestinal Biodegradable Stents Market: Trends

Figure 7: Global Gastrointestinal Biodegradable Stents Market: Opportunity

Figure 8: Global Gastrointestinal Biodegradable Stents Market: Restraint

Figure 9: Global Gastrointestinal Biodegradable Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gastrointestinal Biodegradable Stents Market Value (USD Million) By Region

Figure 19: Global Gastrointestinal Biodegradable Stents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gastrointestinal Biodegradable Stents Market Value (USD Million) By Region

Figure 27: Global Gastrointestinal Biodegradable Stents Market Share (%) By: Regions (2032)

Figure 28: Global Gastrointestinal Biodegradable Stents Market Volume (K) By Region

Figure 29: Global Gastrointestinal Biodegradable Stents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gastrointestinal Biodegradable Stents Market Value (USD Million) By Region

Figure 37: Global Gastrointestinal Biodegradable Stents Market Share (%) By: Regions (2032)

Figure 38: Global Gastrointestinal Biodegradable Stents Market Volume (K) By Region

Figure 39: Global Gastrointestinal Biodegradable Stents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Gastrointestinal Biodegradable Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gastrointestinal Biodegradable Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gastrointestinal Biodegradable Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gastrointestinal Biodegradable Stents Market Value (USD Million) By Region

Table 14: Global Gastrointestinal Biodegradable Stents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gastrointestinal Biodegradable Stents Market Volume (K) By Region

Table 31: Global Gastrointestinal Biodegradable Stents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gastrointestinal Biodegradable Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gastrointestinal Biodegradable Stents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gastrointestinal Biodegradable Stents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Cook Group Basic Information And Sales Area

Table 54: Cook Group. Products Portfolio

Table 55: Micro-Tech Basic Information And Sales Area

Table 56: Micro-Tech. Products Portfolio

Table 57: Taewoong Medical Basic Information And Sales Area

Table 58: Taewoong Medical. Products Portfolio

Table 59: Olympus Basic Information And Sales Area

Table 60: Olympus. Products Portfolio

Table 61: Merit Medical Basic Information And Sales Area

Table 62: Merit Medical. Products Portfolio

Table 63: BD Basic Information And Sales Area

Table 64: BD. Products Portfolio

Table 65: ELLA-CS Basic Information And Sales Area

Table 66: ELLA-CS. Products Portfolio

Table 67: Medtronic Basic Information And Sales Area

Table 68: Medtronic. Products Portfolio

Table 69: BVM Medical Basic Information And Sales Area

Table 70: BVM Medical. Products Portfolio

Table 71: ConMed Basic Information And Sales Area

Table 72: ConMed. Products Portfolio

Table 73: Endo-Flex Basic Information And Sales Area

Table 74: Endo-Flex. Products Portfolio

Table 75: Cantel Medical Basic Information And Sales Area

Table 76: Cantel Medical. Products Portfolio

Table 77: Hobbs Medical Basic Information And Sales Area

Table 78: Hobbs Medical. Products Portfolio

Table 79: MITech Basic Information And Sales Area

Table 80: MITech. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Gastrointestinal Biodegradable Stents Market Value (USD Million) By Region

Table 90: Global Gastrointestinal Biodegradable Stents Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Gastrointestinal Biodegradable Stents Market Volume (K) By Region

Table 107: Global Gastrointestinal Biodegradable Stents Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current Gastrointestinal Biodegradable Stents market size?

The Gastrointestinal Biodegradable Stents market size was valued at approximately USD 1.1 billion in 2023, reflecting steady adoption across gastroenterology clinics and early‑stage reimbursement approvals in major economies and growing interest from interventional endoscopists seeking minimally invasive solutions for benign and malignant strictures.

2. What is the projected growth rate for the market?

Forecasts indicate the Gastrointestinal Biodegradable Stents market will expand at a compound annual growth rate of 6.2 % between 2024 and 2032, driven by aging populations, rising incidence of gastrointestinal obstructions, and increasing physician confidence in bio‑resorbable technologies.

3. Which factors are the primary drivers of market expansion?

Key drivers include the demand for temporary scaffolding that eliminates long‑term foreign‑body complications, advances in polymer engineering that improve radial strength, and reimbursement incentives in Europe and Asia that encourage adoption of biodegradable solutions over metal stents.

4. What challenges could hinder market growth?

Challenges comprise limited long‑term clinical data, variability in degradation timelines across polymer grades, higher upfront costs relative to conventional stents, and stringent regulatory pathways that may delay product launches in North America and emerging markets.

5. Which regions lead the Gastrointestinal Biodegradable Stents market?

Europe currently leads, driven by Germany, France, and the UK’s early reimbursement frameworks; North America follows with strong research activity, while Asia‑Pacific shows rapid acceleration, especially in Japan, China, and South Korea, due to expanding endoscopy networks.

6. Who are the top companies competing in this space?

Leading players include Boston Scientific, Medtronic, MicroPort, Taewoong Medical, and Meril Life Sciences, each investing in next‑generation polymer blends, strategic partnerships with academic centers, and geographic expansion to capture market share across high‑growth regions globally.

7. What future opportunities are emerging for the market?

Emerging opportunities involve combining biodegradable scaffolds with drug‑eluting coatings for anti‑inflammatory effects, expanding indications to postoperative anastomotic leaks, and leveraging AI‑guided imaging to personalize stent sizing, which could unlock new revenue streams and clinical adoption.

8. How is technology shaping the market’s future outlook?

Advances in bioresorbable polymer chemistry, 3‑D printing for patient‑specific geometries, and smart sensor integration that monitor degradation in real‑time are reshaping the future outlook, enabling clinicians to tailor therapy and reduce post‑procedure complications while also improving patient satisfaction and cost efficiency.

9. What is the regulatory landscape for biodegradable gastrointestinal stents?

Regulatory pathways vary: the EU follows the MDR with a focus on clinical performance, the US FDA requires a de novo or 510(k) submission with long‑term safety data, and Asian regulators are introducing expedited review programs for bio‑resorbable devices.

Contact for Full Report

Loading report content...

Gastrointestinal Biodegradable Stents Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

Gastrointestinal Biodegradable Stents Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gastrointestinal Biodegradable Stents Segmentation

Gastrointestinal Biodegradable Stents Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gastrointestinal Biodegradable Stents market size?

2. What is the projected growth rate for the market?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Gastrointestinal Biodegradable Stents market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology shaping the market’s future outlook?

9. What is the regulatory landscape for biodegradable gastrointestinal stents?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Gastrointestinal Biodegradable Stents Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gastrointestinal Biodegradable Stents Segmentation

Gastrointestinal Biodegradable Stents Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gastrointestinal Biodegradable Stents market size?

2. What is the projected growth rate for the market?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Gastrointestinal Biodegradable Stents market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology shaping the market’s future outlook?

9. What is the regulatory landscape for biodegradable gastrointestinal stents?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation